Zunfu Ke

5.7k total citations
111 papers, 3.7k citations indexed

About

Zunfu Ke is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zunfu Ke has authored 111 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 48 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Zunfu Ke's work include Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Zunfu Ke is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (12 papers) and Lung Cancer Treatments and Mutations (12 papers). Zunfu Ke collaborates with scholars based in China, United States and Hong Kong. Zunfu Ke's co-authors include Liantang Wang, Weiling He, Shuhua Li, Hsian‐Rong Tseng, Jie‐Fu Chen, Wenting Jiang, Millicent Lin, Yongmei Cui, Hui Zhang and Shuang Hou and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Zunfu Ke

107 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zunfu Ke China 37 1.6k 1.4k 966 667 600 111 3.7k
Minjiang Chen China 35 1.8k 1.1× 1.1k 0.8× 903 0.9× 581 0.9× 1.2k 1.9× 197 4.0k
Karuna Ganesh United States 14 1.4k 0.9× 1.7k 1.2× 818 0.8× 828 1.2× 584 1.0× 37 3.4k
Lynn G. Feun United States 39 2.2k 1.4× 1.8k 1.3× 1.1k 1.1× 679 1.0× 817 1.4× 207 5.7k
Rongcheng Luo China 35 2.4k 1.6× 1.1k 0.8× 1.3k 1.3× 502 0.8× 686 1.1× 207 4.2k
Amalia Azzariti Italy 37 1.9k 1.2× 1.4k 1.0× 601 0.6× 334 0.5× 445 0.7× 132 3.6k
Hao Xiong United States 29 2.0k 1.3× 1.6k 1.1× 377 0.4× 492 0.7× 412 0.7× 132 4.4k
Judy R. van Beijnum Netherlands 29 1.8k 1.1× 1.2k 0.9× 721 0.7× 695 1.0× 497 0.8× 53 3.6k
Xueli Bai China 37 1.8k 1.2× 1.5k 1.0× 1.2k 1.2× 825 1.2× 515 0.9× 154 4.2k
Weiling He China 31 1.9k 1.2× 877 0.6× 1.2k 1.2× 557 0.8× 473 0.8× 94 3.7k
Suxia Luo China 25 1.3k 0.8× 2.0k 1.4× 745 0.8× 993 1.5× 793 1.3× 108 3.5k

Countries citing papers authored by Zunfu Ke

Since Specialization
Citations

This map shows the geographic impact of Zunfu Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunfu Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunfu Ke more than expected).

Fields of papers citing papers by Zunfu Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunfu Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunfu Ke. The network helps show where Zunfu Ke may publish in the future.

Co-authorship network of co-authors of Zunfu Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Zunfu Ke. A scholar is included among the top collaborators of Zunfu Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunfu Ke. Zunfu Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ge, Minghua, Xuan-Yu Chen, Ping Huang, et al.. (2025). Understanding and overcoming multidrug resistance in cancer. Nature Reviews Clinical Oncology. 22(10). 760–780. 10 indexed citations
3.
Jiang, Zewei, Zunfu Ke, Liang Zhang, et al.. (2025). Nanodrug-based therapeutic interventions for tumor-associated microbiota modulation. Journal of Controlled Release. 387. 114196–114196.
4.
Zhou, Yi, Zhixin Guo, Jianyan Long, et al.. (2025). Surgical Optimization in Preoperatively Low-risk cN1a PTC: A Predictive Model for High-Volume Central Lymph Node Metastasis. Annals of Surgical Oncology. 33(2). 1307–1318.
5.
6.
Feng, Yanhui, Juan Xiong, Ge Lin, et al.. (2024). Exploring IAA biosynthesis and plant growth promotion mechanism for tomato root endophytes with incomplete IAA synthesis pathways. Chemical and Biological Technologies in Agriculture. 11(1). 7 indexed citations
7.
Liu, Bixia, Yuting Luo, Yanxia Wang, et al.. (2023). New insights into the correlations between circulating tumor cells and target organ metastasis. Signal Transduction and Targeted Therapy. 8(1). 465–465. 72 indexed citations
8.
Long, Lingli, Tengfei Long, Xiaofang Lu, et al.. (2021). Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. Journal for ImmunoTherapy of Cancer. 9(12). e003973–e003973. 44 indexed citations
10.
Ma, Xiaoshi, Jinan Guo, Kaisheng Liu, et al.. (2020). Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Molecular Cancer. 19(1). 147–147. 61 indexed citations
11.
Lin, Run, Hui Zhang, Yujie Yuan, et al.. (2020). Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research. 8(4). 479–492. 169 indexed citations
12.
Sun, Yu, Yangshan Chen, Ji Cui, et al.. (2020). Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). International Immunopharmacology. 80. 106198–106198. 80 indexed citations
13.
Dong, Jiantong, Jie‐Fu Chen, Matthew Smalley, et al.. (2019). Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced Materials. 32(1). e1903663–e1903663. 83 indexed citations
14.
Long, Lingli, Yubin Li, Shuang Yu, et al.. (2019). Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling. Journal of Diabetes Research. 2019. 1–17. 48 indexed citations
15.
16.
Ke, Zunfu, Yihao Liu, Yunjian Zhang, et al.. (2018). Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer. Oncology Reports. 40(2). 659–668. 9 indexed citations
17.
Li, Shuhua, et al.. (2014). Expression of astrocyte elevated gene-1 closely correlates with the angiogenesis of gastric cancer. Oncology Letters. 7(5). 1447–1454. 11 indexed citations
18.
Zeng, Chao, Zunfu Ke, Yulan Song, et al.. (2013). Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance. Experimental and Molecular Pathology. 95(1). 23–31. 39 indexed citations
19.
Zhu, Junfeng, Yupeng Feng, Zunfu Ke, et al.. (2012). Down-Regulation of miR-183 Promotes Migration and Invasion of Osteosarcoma by Targeting Ezrin. American Journal Of Pathology. 180(6). 2440–2451. 121 indexed citations
20.
Zhang, Yunjian, Wenjian Wang, Zunfu Ke, et al.. (2010). Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis. Journal of Vascular Surgery. 53(3). 743–753. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026